Table 2.
The “Placebo”/“Standard” hazard ratios of 10 MA studies as presented in FDA Guidance Example 4; the “New”/“Standard” HR is also shown for the corresponding noninferiority(NI) Study 2 (Food and Drug Administration, 2010)
Study | Hazard ratio | Log hazard ratio | SE (log hazard ratio) |
MA 1 | 1.35 | 0.301 | 0.232 |
MA 2 | 1.26 | 0.235 | 0.188 |
MA 3 | 0.78 | –0.253 | 0.171 |
MA 4 | 1.15 | 0.143 | 0.153 |
MA 5 | 1.39 | 0.329 | 0.185 |
MA 6 | 1.35 | 0.300 | 0.184 |
MA 7 | 1.38 | 0.324 | 0.166 |
MA 8 | 1.34 | 0.294 | 0.126 |
MA 9 | 1.03 | 0.0296 | 0.165 |
MA 10 | 1.95 | 0.670 | 0.172 |
NI 0 | 0.92 | –0.0844 | 0.0867 |